Paratek Pharmaceuticals

Investor NexPoint has threatened to prevent the $462 million sale of Paratek - Pharmtales - Latest Pharma News & Analysis

Investor NexPoint has threatened to prevent the $462 million sale of Paratek

SG Tylor

Source – Paratek Pharmaceuticals On 29 June, Paratek Pharmaceuticals is scheduled to hold its annual meeting, but a contentious situation ...